Brief: China Nt Pharma Group Says Transferred Pfenex Rights To NT Pharma International

China NT Pharma Co

27/04/2020 15:59

April 27 (Reuters) - China NT Pharma Group Company Ltd
 1011.HK :
    * TRANSFERRED RIGHTS UNDER PFENEX AGREEMENT TO NT PHARMA
INTERNATIONAL ON 21 APRIL
    * APPLICATION MADE FOR RESUMPTION OF TRADING OF SHARES ON
STOCK
EXCHANGE FROM 9 A.M. ON 28 APRIL
    * NT PHARMA OVERSEAS TO DISPOSE SHARE CAPITAL OF NT PHARMA
INTERNATIONAL TO KANGCHEN
    * NT PHARMA PACIFIC TO SUBSCRIBE FOR 40% STAKE IN BEIJING
KANGCHEN
BIOLOGICAL TECHNOLOGY
    * CONSIDERATION FOR ACQUISITION OF 40% STAKE IN KANGCHEN IS
RMB360.0 MILLION
    * CHINA NT PHARMA GROUP SEES ESTIMATED GAIN OF ABOUT RMB34.1
MILLION ON PROPOSED DISPOSAL OF NT PHARMA INTERNATIONAL SHARES
BY NT PHARMA OVERSEAS

Source text for Eikon:  urn:newsml:reuters.com:*:nHKS35VcmR
Further company coverage:  1011.HK 

 (Reuters.Briefs@thomsonreuters.com)